BL
Belite Bio, Inc (BLTE)
NASDAQ·Healthcare·Biotechnology
$155.88
+1.08%
Mkt Cap $6.72B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (17 analysts)
$238.33
Range $206.00 – $303.00
Implied Upside
+52.9%
Consensus $238.33 vs current $155.88
NASDAQ·Healthcare·Biotechnology
$155.88
+1.08%
Mkt Cap $6.72B
Buy
3
Hold
0
Sell
0
Price Target (17 analysts)
$238.33
Range $206.00 – $303.00
+52.9%
Consensus $238.33 vs current $155.88